Across TCGA pan-cancer cohorts, RPL7P7 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPL7P7’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where RPL7P7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL7P7 is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.

LIHC, COAD, and LUSC are the cancer types where RPL7P7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL7P7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.053	.005	5	view →
COAD	Male	IV	+0.550	.028	3	view →
LUSC	Female	III,IV	−0.265	.003	2	view →
CHOL	Male	All	+0.110	<.001	2	view →
LUAD	All	All	+0.226	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RPL7P7 RNA expression & survival · all RPL7P7 data types